Ads
related to: Parkinson’s disease
Search results
Sage Therapeutics stock plunges 23 percent after Parkinson’s drug fails study - The Boston Globe
The Boston Globe· 7 days agoShares of Sage Therapeutics hit a record low Wednesday after the Cambridge biotech announced that...
Groundbreaking AI Method Identifies New Parkinson’s Treatments 10x Faster
SciTechDaily· 3 days agoResearchers have leveraged artificial intelligence methods to significantly speed up the discovery...
Michael J. Fox Says He Is Open to Acting Again for the Right Role
My Modern Met· 23 hours agoActor Michael J. Fox has given us some of the most memorable roles in film and TV. In 2020, Fox...
Sage Therapeutics down 19% as its Parkinson's drug fails Phase 2 trials By Investing.com
Investing.com· 7 days agoSage Therapeutics (SAGE) announced on Wednesday that it will halt the development of its...
AI Revolutionizes Hunt for Parkinson's Treatments - Neuroscience News
Neuroscience News· 7 days agoSummary: Researchers employed AI to fast-track the discovery of treatments for Parkinson’s disease....
No one should face Parkinson’s disease alone
Galveston County Daily News· 2 days agoParkinson’s disease is a devastating brain disorder that causes many physical and mental problems.
AbbVie buyout Cerevel marks trial win for Parkinson’s drug
Seeking Alpha· 6 days agoAbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its ...
Ryan Reynolds honors Michael J. Fox for helping people with Parkinson’s disease, including his late...
WKBT La Crosse· 7 days ago“Not just because he has Parkinson’s. He falls a lot because he’s unafraid to fly.” This week,...
Parkinson's symposium April 26 at Cd'A Public Library
Coeur d'Alene Press· 6 days agoIt's Parkinson's Disease Awareness Month, named in honor of James Parkinson, who was the first ...
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
BioPharma Dive via Yahoo Finance· 6 days agoCerevel Therapeutics, a biotechnology company in the midst of being acquired by AbbVie, on Thursday...
Ads
related to: Parkinson’s disease